Pancreatic Cancer Research

ResearcherUSA Mitchell Cancer InstituteNo recent work listed

Sanjeev K. Srivastava

Matched on ORCID iD 0000-0002-0074-2122; OpenAlex author ID A5103020810. Sources: OpenAlex.

Their work

Papers
14 (first author 3, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
15
Papers, trials and grants by year

2011: 2 papers · 2012: 1 paper · 2013: 1 paper · 2014: 1 paper · 2015: 3 papers · 2016: 3 papers · 2017: 1 paper · 2018: none · 2019: none · 2020: 1 paper · 2021: none · 2022: none · 2023: 1 paper

Papers 14

  1. MYB sustains hypoxic survival of pancreatic cancer cells by facilitating metabolic reprogramming. Co-author DOI 10.15252/embr.202255643↗
  2. Co-targeting of CXCR4 and hedgehog pathways disrupts tumor-stromal crosstalk and improves chemotherapeutic efficacy in pancreatic cancer. First author DOI 10.1074/jbc.ra119.011748↗
  3. Exosomes confer chemoresistance to pancreatic cancer cells by promoting ROS detoxification and miR-155-mediated suppression of key gemcitabine-metabolising enz… Co-author DOI 10.1038/bjc.2017.18↗
  4. p-21 activated kinase 4 (PAK4) maintains stem cell-like phenotypes in pancreatic cancer cells through activation of STAT3 signaling. Co-author DOI 10.1016/j.canlet.2015.10.028↗
  5. Deep sequencing and in silico analyses identify MYB-regulated gene networks and signaling pathways in pancreatic cancer. Co-author DOI 10.1038/srep28446↗
  6. MYB Promotes Desmoplasia in Pancreatic Cancer through Direct Transcriptional Up-regulation and Cooperative Action of Sonic Hedgehog and Adrenomedullin. First author DOI 10.1074/jbc.m116.732651↗
  7. Insights into the Role of microRNAs in Pancreatic Cancer Pathogenesis: Potential for Diagnosis, Prognosis, and Therapy. Co-author DOI 10.1007/978-3-319-23730-5_5↗
  8. MicroRNA-345 induces apoptosis in pancreatic cancer cells through potentiation of caspase-dependent and -independent pathways. Co-author DOI 10.1038/bjc.2015.252↗
  9. Gemcitabine triggers angiogenesis-promoting molecular signals in pancreatic cancer cells: Therapeutic implications. First author DOI 10.18632/oncotarget.3784↗
  10. Synthesis, characterization, and evaluation of poly (D,L-lactide-co-glycolide)-based nanoformulation of miRNA-150: potential implications for pancreatic cancer… Co-author DOI 10.2147/ijn.s61949↗
  11. An undesired effect of chemotherapy: gemcitabine promotes pancreatic cancer cell invasiveness through reactive oxygen species-dependent, nuclear factor κB- and… Co-author DOI 10.1074/jbc.m113.484576↗
  12. CXCL12/CXCR4 protein signaling axis induces sonic hedgehog expression in pancreatic cancer cells via extracellular regulated kinase- and Akt kinase-mediated ac… Co-author DOI 10.1074/jbc.m112.409581↗
  13. MicroRNA-150 directly targets MUC4 and suppresses growth and malignant behavior of pancreatic cancer cells. Co-author DOI 10.1093/carcin/bgr223↗
  14. Honokiol arrests cell cycle, induces apoptosis, and potentiates the cytotoxic effect of gemcitabine in human pancreatic cancer cells. Co-author DOI 10.1371/journal.pone.0021573↗

Closest collaborators

The 15 strongest of 15 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Ajay P. Singh · 14 shared papers, 2011–2023 · strength 0.87
  2. Seema Singh · 13 shared papers, 2011–2023 · strength 0.83
  3. Arun Bhardwaj · 11 shared papers, 2011–2017 · strength 0.52
  4. Mohammad Aslam Khan · 5 shared papers, 2015–2023 · strength 0.47
  5. Moh'd M. Khushman · 4 shared papers, 2016–2020 · strength 0.30
  6. Sumit Arora · 7 shared papers, 2011–2016 · strength 0.29
  7. Shafquat Azim · 2 shared papers, 2016–2023 · strength 0.24
  8. Sachin Kumar Deshmukh · 2 shared papers, 2016–2023 · strength 0.24
  9. Girijesh Kumar Patel · 2 shared papers, 2017–2020 · strength 0.18
  10. Kunwar Somesh Vikramdeo · 1 shared paper, 2023 · strength 0.18
  11. Shashi Anand · 1 shared paper, 2023 · strength 0.18
  12. Nikhil Tyagi · 3 shared papers, 2015–2016 · strength 0.17
  13. Mary C. Patton · 1 shared paper, 2017 · strength 0.07
  14. Jayanth Panyam · 1 shared paper, 2014 · strength 0.04
  15. Gary Anthony Piazza · 1 shared paper, 2013 · strength 0.03

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.